Referenties
1. P. Van Damme, R. Burgmeijer. Hepatitis B. In: R. Burgmeijer, K. Hoppenbrouwers, N. Bolscher (eds.). Handboek Vaccinaties. Van Gorcum, 2007.
2. Centres for Disease Control. Epidemiology and prevention of vaccine preventable diseases (pink book). 8th ed. 2005.
3. Poland GA, Jacobson RM. Prevention of hepatitis B with the hepatitis B vaccine. NEJM 2004; 351: 2832-38.
4. Meheus A. Teenagers' lifestyle and the risk of exposure to hepatitis B virus. Vaccine 2000; 18: 26-9.
5. De Schrijver K. De epidemiologie van seksueel overdraagbare aandoeningen in België. Epidemiologisch Bulletin van de Vlaamse Gemeenschap 2003; 45: 1-7.
6. Clinical Effectiveness Group. National guideline for the management of the viral hepatitides A, B and C. Sex Trans Inf 1999; 75 suppl 1: 57-64.
7. Francois G, Hallauer J, Van Damme P. Hepatitis B vaccination: how to reach risk groups. Vaccine 2002; 21: 1-4.
8. Jaarverslag Gezondheidshuis Antwerpse Prostitutie 2003. www.ghapro.be.
9. Castermans S, Verheyen J. Een preventief gezondheidsprogramma voor prostitué(e)s in Antwerpen: noodzaak en haalbaarheid. Eindwerk ter verkrijging van het diploma arts. 2005.
10. European Consensus Group on Hepatitis B immunity. Are booster immunisations needed for lifelong hepatitis B immunity. Lancet 2000; 355: 561-65.
11. Keating GM, Noble S. Recombinant hepatitis B vaccine ( Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B. Drugs 2003; 63: 1021-51.
12. Christensen PB, Fisker N, Krarup HB et al. Hepatitis B vaccination in prison with a 3-week schedule is more efficient than the standard 6-month schedule. Vaccine 2004; 22: 3897-3901.
13. Bhatti N, Gilson RJC, Beecham M et al. Failure to deliver hepatitis B vaccine: confessions from a genitourinairy medicine clinic. BMJ 1991; 301: 97-101.
14. Jalleel H, Allen PS, Huengsberg M et al. Offering the vaccine and accepting it: an audit of hepatitis B vaccination in West Midlands region . Int J STD AIDS 2003; 14: 632-35.
15. Sellors J, Pickard L, Mahony JB et al. Understanding and enhancing compliance with the second dose of hepatitis B vaccine: a cohort analysis and randomized controled trial . Can Med Assoc J 1997; 157: 143-8.
16. Wouters K, Van Damme P, Vercauteren A. Sexually transmitted infections among prositutes in Antwerp, Belgium. Arch Public Health 2002; 60: 27-38.
17. Van Steenbergen J. Results of an enhanced outreach programme of hepatitis B vaccination in the Netherlands ( 1998-2000) among men who have sex with men, hard drug users, sex workers and heterosexual persons with multiple partners. J of Hept 2002; 37: 507-13.
18. Mak R, Traen A, Claeyssen M et al. Hepatitis B vaccination for sex workers: do outreach programmes perform better? Sex Transm Infect 2003; 79: 157-9.
19. Van Ardenne N, Roelofs I, Leuridan E et al. Audit on offering the hepatitis B vaccine and accepting it in sex workers [letter]. Int J STD AIDS 2004; 15: 493-4.
20. Roelofs I, Van Ardenne N, Leuridan E et al. Sex workers in Antwerp (Belgium): how feasible is the hepatitis B vaccination programme? Presentatie Leiden International Medical Student Congress 2005
21. Dal-Ré R, González A, Ramirez V, et al. Compliance with immunization against hepatitis B. A pragmatic study in sexually transmitted disease clinics. Vaccine 1995 ; 13 : 163-7.
22. Hess G, Hingst V, Cseke J, et al. Influence of vaccination schedules and host factors on antibody respons following hepatitis B vaccination. Eur J Clin Microbiol Inf Dis 1992; 11: 334-40.
23. Zuckerman JN. The place of accelerated schedules for hepatitis A and B vaccinations., Drugs 2003; 63: 1779-84.
24. Bock HL, Loscher T, Scheiermann N et al. Accelerated schedule for hepatitis B immunization. J Travel Med 1995; 2: 213-7.
25. Jilg W, Schmidt M, Deinhardt F. Vaccination against hepatitis B: comparison of three different vaccination schedules. J Inf Dis 1989; 160: 766-9.
26. Saltoglu N, Inal AS, Tasova Y et al. Comparison of the accelerated and classic vaccination schedule against hepatitis: three-week hepatitis B vaccination schedule provides immediate and protective immunity. Ann Clin Microbiol Antimicrob 2003; 2.
27. Marsano L, Greenberg RN, Kirkpatrick RB et al. Comparison of a rapid hepatitis B immunization schedule to the standard schedule for adults. J Gastroenterol 1996; 91: 111-15.
28. Wilkinson SE, Morath M, Bennet BL et al. Accelerated schedule of hepatitis B vaccination in high-risk youth. Paediatr Child Health 1996; 32: 60-2.
29. Marchou B, Excel JL, Bourderioux C, et al. A 3-week hepatitis B vaccination schedule provides rapid and persistent protective immunity: a multicenter, randomized trial comparing accelerated and classic vaccination schedules. J Inf Dis 1995; 172: 258-60.
30. Jones O, Sankar KN. Audit of outcome of super-accelerated hepatitis B vaccination schedule in a genitourinairy medicine clinic. Int J STD AIDS 2005; 16: 636-7.
31. Opaneye AA, Bashford J. Audit of hepatitis B immunization at the genitourinairy medicine department in Middlesbrough, UK. Int J STD AIDS 2002; 13: 268-70.
32. Asboe D, Rice P, De Ruiter A et al. Hepatitis B vaccination schedules in genitourinairy medicine clinics. Genitourin Med 1996; 72: 210-2.
33. Burgess MA, Rodger AJ, Wait SA, et al. Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study.Vaccine 2001;19 : 4835-41.
34. Wouters K, Leuridan E, Van Herck, Van Ardenne N, Roelofs I, Mak R, Prévost C, Guérin P, Denis B, Van Damme P. Compliance and Immunogenicity of two hepatitis B vaccination schedules in sex workers in Belgium. Vaccine 2007;25: 1893-1900.
35. Leuridan E, Wouters K, Stalpaert M et al. Male sex workers in Antwerp, Belgium: a descriptive study. Int J STD AIDS 2005; 16: 744-8.
36. Zuckerman J. The place of accelerated schedules for hepatits A and B vaccination. Drugs 2003; 63: 1779-84.
37. Van Herck K, Leuridan E, Van Damme P. Schedules for heptitis B vaccination of risk groups: balancing immunogenicity and compliance. Ingediend bij Int J STD AIDS
38. Bhaduri S, Gosling C. Audit of hepatitis B immunization ( letter). Int J STD AIDS 2003;14: 65.